Clinical Trials List
Protocol NumberCDRB436J12301
Active
2021-09-06 - 2027-08-30
Phase III
Recruiting2
ICD-9193
Malignant neoplasm of thyroid gland
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- SHYANG-RONG SHIH 無
- 呂金盈 無
- 吳宗哲 無
- 徐偉勛 無
- Jih-Hsiang Lee 無
- 林昭文 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊舜如 無
- Liu Yi-Sheng 無
- Shang-Hung Chen 無
- 陳婉如 無
- 洪崇傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
150 participants
